ORACLE CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ORACLE CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $57.40B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $52.96B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $49.95B | Jun 18, 2025 |
| FY2022 | May 31, 2022 | $42.44B | Jun 21, 2022 |
| FY2022 | May 31, 2021 | $40.48B | Jun 21, 2022 |
| FY2022 | May 31, 2020 | $39.07B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $39.51B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $39.38B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $37.79B | Jun 21, 2019 |
| FY2018 | May 31, 2016 | $37.05B | Jun 22, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $57.40B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $52.96B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $49.95B | Jun 18, 2025 |
| FY2024 | May 31, 2022 | $42.44B | Jun 20, 2024 |
| FY2023 | May 31, 2021 | $40.48B | Jun 20, 2023 |
| FY2022 | May 31, 2020 | $39.07B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $39.51B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $39.38B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $37.79B | Jun 21, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | May 31, 2011 | $6.94B | Jun 28, 2011 |
| FY2010 | May 31, 2010 | $2.29B | Jul 1, 2010 |
| FY2010 | May 31, 2009 | $0 | Jul 1, 2010 |
| FY2010 | May 31, 2008 | $0 | Jul 1, 2010 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | May 31, 2018 | $24.29B | Jun 22, 2018 |
| FY2018 | May 31, 2017 | $23.02B | Jun 22, 2018 |
| FY2018 | May 31, 2016 | $22.41B | Jun 22, 2018 |
| FY2017 | May 31, 2015 | $23.71B | Jun 27, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $12.44B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $10.47B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $8.50B | Jun 18, 2025 |
| FY2024 | May 31, 2022 | $6.72B | Jun 20, 2024 |
| FY2023 | May 31, 2021 | $13.75B | Jun 20, 2023 |
| FY2022 | May 31, 2020 | $10.14B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $11.08B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $3.59B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $9.45B | Jun 21, 2019 |
| FY2018 | May 31, 2016 | $8.90B | Jun 22, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $17.68B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $15.35B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $13.09B | Jun 18, 2025 |
| FY2024 | May 31, 2022 | $10.93B | Jun 20, 2024 |
| FY2023 | May 31, 2021 | $15.21B | Jun 20, 2023 |
| FY2022 | May 31, 2020 | $13.90B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $13.54B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $13.26B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $12.91B | Jun 21, 2019 |
| FY2018 | May 31, 2016 | $12.60B | Jun 22, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $9.86B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $8.92B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $8.62B | Jun 18, 2025 |
| FY2024 | May 31, 2022 | $7.22B | Jun 20, 2024 |
| FY2023 | May 31, 2021 | $6.53B | Jun 20, 2023 |
| FY2022 | May 31, 2020 | $6.07B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $6.03B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $6.08B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $6.15B | Jun 21, 2019 |
| FY2018 | May 31, 2016 | $5.79B | Jun 22, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $20.82B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $18.67B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $17.17B | Jun 18, 2025 |
| FY2024 | May 31, 2022 | $9.54B | Jun 20, 2024 |
| FY2023 | May 31, 2021 | $15.89B | Jun 20, 2023 |
| FY2022 | May 31, 2020 | $13.14B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $14.55B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $15.39B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $14.13B | Jun 21, 2019 |
| FY2018 | May 31, 2016 | $13.69B | Jun 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $21.22B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $6.87B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $8.70B | Jun 18, 2025 |
| FY2024 | May 31, 2022 | $4.51B | Jun 20, 2024 |
| FY2023 | May 31, 2021 | $2.14B | Jun 20, 2023 |
| FY2022 | May 31, 2020 | $1.56B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $1.66B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $1.74B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $2.02B | Jun 21, 2019 |
| FY2018 | May 31, 2016 | $1.19B | Jun 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $168.36B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $140.98B | Jun 18, 2025 |
| FY2024 | May 31, 2023 | $134.38B | Jun 20, 2024 |
| FY2023 | May 31, 2022 | $109.30B | Jun 20, 2023 |
| FY2022 | May 31, 2021 | $131.11B | Jun 21, 2022 |
| FY2021 | May 31, 2020 | $115.44B | Jun 21, 2021 |
| FY2020 | May 31, 2019 | $108.71B | Jun 22, 2020 |
| FY2019 | May 31, 2018 | $137.85B | Jun 21, 2019 |
| FY2018 | May 31, 2017 | $134.99B | Jun 22, 2018 |
| FY2017 | May 31, 2016 | $112.18B | Jun 27, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $20.45B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $8.70B | Jun 18, 2025 |
| FY2024 | May 31, 2023 | $1.07B | Jun 20, 2024 |
| FY2023 | May 31, 2022 | ($6.22B) | Jun 20, 2023 |
| FY2022 | May 31, 2021 | $5.24B | Jun 21, 2022 |
| FY2021 | May 31, 2020 | $12.07B | Jun 21, 2021 |
| FY2020 | May 31, 2019 | $21.79B | Jun 22, 2020 |
| FY2019 | May 31, 2018 | $46.37B | Jun 21, 2019 |
| FY2018 | May 31, 2017 | $53.86B | Jun 22, 2018 |
| FY2017 | May 31, 2016 | $47.29B | Jun 27, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $62.21B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $62.23B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $62.26B | Jun 18, 2025 |
| FY2024 | May 31, 2022 | $43.81B | Jun 20, 2024 |
| FY2023 | May 31, 2021 | $43.94B | Jun 20, 2023 |
| FY2022 | May 31, 2020 | $43.77B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $43.78B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $43.76B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $43.05B | Jun 21, 2019 |
| FY2018 | May 31, 2016 | $34.59B | Jun 22, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($15.48B) | Jun 18, 2025 |
| FY2025 | May 31, 2024 | ($22.63B) | Jun 18, 2025 |
| FY2024 | May 31, 2023 | ($27.62B) | Jun 20, 2024 |
| FY2023 | May 31, 2022 | ($31.34B) | Jun 20, 2023 |
| FY2022 | May 31, 2021 | ($20.12B) | Jun 21, 2022 |
| FY2021 | May 31, 2020 | ($12.70B) | Jun 21, 2021 |
| FY2020 | May 31, 2019 | ($3.50B) | Jun 22, 2020 |
| FY2019 | May 31, 2018 | $19.11B | Jun 21, 2019 |
| FY2018 | May 31, 2017 | $27.60B | Jun 22, 2018 |
| FY2017 | May 31, 2016 | $23.89B | Jun 27, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $10.79B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $10.45B | Jun 18, 2025 |
| FY2024 | May 31, 2023 | $9.77B | Jun 20, 2024 |
| FY2023 | May 31, 2022 | $21.38B | Jun 20, 2023 |
| FY2022 | May 31, 2021 | $30.10B | Jun 21, 2022 |
| FY2021 | May 31, 2020 | $37.24B | Jun 21, 2021 |
| FY2020 | May 31, 2019 | $20.51B | Jun 22, 2020 |
| FY2019 | May 31, 2018 | $21.62B | Jun 21, 2019 |
| FY2018 | May 31, 2017 | $21.78B | Jun 22, 2018 |
| FY2018 | May 31, 2016 | $20.15B | Jun 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | May 31, 2022 | $0 | Jun 21, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 4 | Jun 18, 2025 |
| FY2025 | May 31, 2024 | 3 | Jun 18, 2025 |
| FY2025 | May 31, 2023 | 3 | Jun 18, 2025 |
| FY2024 | May 31, 2022 | 2 | Jun 20, 2024 |
| FY2023 | May 31, 2021 | 4 | Jun 20, 2023 |
| FY2022 | May 31, 2020 | 3 | Jun 21, 2022 |
| FY2021 | May 31, 2019 | 3 | Jun 21, 2021 |
| FY2020 | May 31, 2018 | 0 | Jun 22, 2020 |
| FY2019 | May 31, 2017 | 2 | Jun 21, 2019 |
| FY2018 | May 31, 2016 | 2 | Jun 22, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 4 | Jun 18, 2025 |
| FY2025 | May 31, 2024 | 3 | Jun 18, 2025 |
| FY2025 | May 31, 2023 | 3 | Jun 18, 2025 |
| FY2024 | May 31, 2022 | 2 | Jun 20, 2024 |
| FY2023 | May 31, 2021 | 4 | Jun 20, 2023 |
| FY2022 | May 31, 2020 | 3 | Jun 21, 2022 |
| FY2021 | May 31, 2019 | 2 | Jun 21, 2021 |
| FY2020 | May 31, 2018 | 0 | Jun 22, 2020 |
| FY2019 | May 31, 2017 | 2 | Jun 21, 2019 |
| FY2018 | May 31, 2016 | 2 | Jun 22, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 2.81B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | 2.76B | Jun 18, 2025 |
| FY2024 | May 31, 2023 | 2.71B | Jun 20, 2024 |
| FY2023 | May 31, 2022 | 2.67B | Jun 20, 2023 |
| FY2022 | May 31, 2021 | 2.81B | Jun 21, 2022 |
| FY2021 | May 31, 2020 | 3.07B | Jun 21, 2021 |
| FY2020 | May 31, 2019 | 3.36B | Jun 22, 2020 |
| FY2020 | May 31, 2018 | 4.00B | Jun 22, 2020 |
| FY2020 | May 31, 2017 | 4.14B | Jun 22, 2020 |
| FY2019 | May 31, 2016 | 4.13B | Jun 21, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $4.74B | Jun 18, 2025 |
| FY2025 | May 31, 2024 | $4.39B | Jun 18, 2025 |
| FY2025 | May 31, 2023 | $3.67B | Jun 18, 2025 |
| FY2024 | May 31, 2022 | $3.46B | Jun 20, 2024 |
| FY2023 | May 31, 2021 | $3.06B | Jun 20, 2023 |
| FY2022 | May 31, 2020 | $3.07B | Jun 21, 2022 |
| FY2021 | May 31, 2019 | $2.93B | Jun 21, 2021 |
| FY2020 | May 31, 2018 | $3.14B | Jun 22, 2020 |
| FY2019 | May 31, 2017 | $2.63B | Jun 21, 2019 |
| FY2018 | May 31, 2016 | $2.54B | Jun 22, 2018 |